Procurement Summary
State : Delhi (NCT)
Summary : Supply of Adalimumab Inj Each Pre.Filled Syringe to contain: Adalimumab 20mg/ 0.4m1 Composition Adalimumab 20mg, Succinic Acid 0.472mg, Sodium Hydroxide NF Q.S. To pH 5.2 Sodium Chloride USP 2.336mg, L-Arginine Monohydrochloride USP 2mg, Sorbitol NF
Deadline : 31 Oct 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 73691570
Document Ref. No. : Login to see detail
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Document Fees : Refer Document
Tender Value : Refer Document
EMD : Refer Document
Purchaser's Detail
Name : Login to see details
Address : Login to see details
Email : Login to see details
Login to see details
Documents
Tender Notice